UBS analyst Gregor Kuglitsch maintained a Buy rating on Barratt Developments (BTRW – Research Report) today and set a price target of p575.00. The company’s shares opened today at p451.00.

2023 Medical Developments International LtdShs 0.00 0.00 AUD 2022 Medical Developments International LtdShs 0.00 0.00 AUD 2021 Medical Developments International LtdShs 0.00 0.00 AUD 2020 Medical ...

The NYU Production Lab‘s flagship creative incubator, the Feature Film Development Studio, has announced its class of 2025. The cohort-based program works with NYU grad students and alumni to ...

In this documentary, the artist depicts what a more just and beautiful world might look like. By Alissa Wilkinson Ke Huy Quan and Ariana DeBose play reunited former associates from a criminal ...

Dec. 11, 2024 — Gut microbiome composition during pregnancy has long-term effects on offspring stem cell growth and development, researchers report. Treating ... Jan. 17, 2025 — A group of ...